Nano Dimension Ltd.
NNDM Nasdaq Printed Circuit Boards Financials FY2023βFY2025
What Nano Dimension Ltd. does
No business description yet.
- Legal name
- Nano Dimension Ltd.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 31, 2026
- Accession Β· CIK
- 0001193125-26-134641
0001643303
Revenue and margins
Nano Dimension Ltd. had $102M of revenue in fiscal 2025, up 77.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$71.3M in fiscal 2025, β69.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Nano Dimension Ltd. returned β to shareholders in fiscal 2025. The diluted share count fell 1.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Nano Dimension Ltd. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $310M | $317M | $205M |
| Interest coverage | β352.4x | β134.1x | β1,264.2x |
| Current ratio | β | 26.2x | 10.0x |
| Quick ratio | β | 25.7x | 9.4x |
| Total assets | β | $903M | $638M |
| Total liabilities | β | $41.8M | $86.2M |
| Shareholders' equity | $1.0B | $860M | $552M |
| Net debt (β = net cash) | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 5 | 3 / 8 |
| Accruals ratio | β | β8.9% | β29.0% |
| Altman Z'' | β | β | β |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $56.3M | $57.8M | $102M |
| Gross profit | $26.1M | $24.9M | $34.3M |
| Research and development | $65.1M | $39.6M | $30.1M |
| Operating income | β$129M | β$89.6M | β$140M |
| Interest expense | $0.4M | $0.7M | $0.1M |
| Pretax income | β$57.0M | β$99.5M | β$108M |
| Income tax | $0.1M | $0.4M | β$7.2M |
| Net income | β$56.0M | β$98.8M | β$293M |
| Net income to common | β$56.0M | β$98.8M | β$293M |
| Diluted EPS | β$0.23 | β$0.45 | β$1.36 |
| Diluted shares | 0.00B | 0.00B | 0.00B |
| Cash flow | |||
| Cash from operations | β$68.7M | β$18.9M | β$70.3M |
| Capital expenditure | $9.1M | $2.2M | $1.1M |
| Free cash flow | β$77.8M | β$21.1M | β$71.3M |
| Depreciation and amortization | $2.0M | $2.6M | $20.5M |
| Stock-based compensation | $22.1M | $15.7M | $5.9M |
| Acquisitions | $0.0M | $0.0M | $268M |
| Balance sheet | |||
| Cash and short-term investments | $310M | $317M | $205M |
| Current assets | β | $789M | $526M |
| Current liabilities | β | $30.1M | $52.5M |
| Inventory | β | $16.9M | $32.9M |
| Property and equipment, net | β | $14.1M | $24.8M |
| Goodwill | β | $0.0M | $40.4M |
| Intangible assets | β | $2.2M | $19.4M |
| Total assets | β | $903M | $638M |
| Total liabilities | β | $41.8M | $86.2M |
| Shareholders' equity | $1.0B | $860M | $552M |
| Margins | |||
| Gross margin | 46.3% | 43.1% | 33.5% |
| Operating margin | β229.6% | β155.1% | β137.0% |
| EBITDA margin | β226.1% | β150.5% | β117.0% |
| Net margin | β99.4% | β171.1% | β286.3% |
| FCF margin | β138.1% | β36.6% | β69.6% |
| Returns | |||
| Return on capital employed | β | β10.3% | β24.0% |
| Return on equity | β5.5% | β10.5% | β41.5% |
| Return on assets | β | β11.0% | β38.1% |
| Return on tangible equity | β5.5% | β11.5% | β59.6% |
| Growth | |||
| Revenue growth | β | 2.6% | 77.3% |
| Share count change | β | β12.0% | β1.2% |
| Financial health | |||
| Interest coverage | β352.4x | β134.1x | β1,264.2x |
| Current ratio | β | 26.2x | 10.0x |
| Quick ratio | β | 25.7x | 9.4x |
| Capital allocation | |||
| Capex / revenue | 16.2% | 3.8% | 1.0% |
| Stock comp / revenue | 39.3% | 27.2% | 5.7% |
| Quality scores | |||
| Piotroski F-score | β | β | 3.0 |
| Accruals ratio | β | β8.9% | β29.0% |
Source: SEC EDGAR XBRL filings (CIK 0001643303). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.